MedTrace Logo

Psilocybin-assisted Therapy for Treatment of Alcohol Use Disorder

NCT05416229 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2026-03-24

No results posted yet for this study

Summary

Note: The trial is only eligible for citizens of Denmark.

The purpose of this project is to assess the treatment efficacy of a single high dose of psilocybin administered within a protocol of psychological support to patients diagnosed with alcohol use disorder (AUD).

Conditions

Interventions

DRUG

Psilocybin

Psilocybin-assisted therapy

DRUG

Maltodextrin

Placebo-assisted therapy

Sponsors & Collaborators

  • The Neurobiology Research Unit at Copenhagen University Hospital Rigshospitalet

    collaborator UNKNOWN

  • Anders Fink-Jensen, MD, DMSci

    lead OTHER

Principal Investigators

  • Anders Fink-Jensen, Professor · Psychiatric Center Copenhagen, Frederiksberg Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-09-01
Primary Completion
2025-12-22
Completion
2025-12-22

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05416229 on ClinicalTrials.gov